These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 19808312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats.
    Plante E, Couet J, Gaudreau M, Dumas MP, Drolet MC, Arsenault M.
    J Card Fail; 2003 Apr; 9(2):128-40. PubMed ID: 12751134
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of combined aortic regurgitation and systemic hypertension: Insights from an animal model study.
    Couet J, Gaudreau M, Lachance D, Plante E, Roussel E, Drolet MC, Arsenault M.
    Am J Hypertens; 2006 Aug; 19(8):843-50. PubMed ID: 16876685
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Modification of cardiac subcellular remodeling due to pressure overload by captopril and losartan.
    Liu X, Sentex E, Golfman L, Takeda S, Osada M, Dhalla NS.
    Clin Exp Hypertens; 1999 Aug; 21(1-2):145-56. PubMed ID: 10052650
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 9. Combined effects of low-dose spironolactone and captopril therapy in a rat model of genetic hypertrophic cardiomyopathy.
    de Resende MM, Kriegel AJ, Greene AS.
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):265-73. PubMed ID: 17204904
    [Abstract] [Full Text] [Related]

  • 10. Cardiac renin-angiotensin system: role in development of pressure-overload hypertrophy.
    Lorell BH.
    Can J Cardiol; 1995 Aug; 11 Suppl F():7F-12F. PubMed ID: 7664219
    [Abstract] [Full Text] [Related]

  • 11. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE, Dahlström U, Gøtzsche O, Lahiri A, Skagen K, Andersen GS, Egstrup K, OPTIMAAL Study Group.
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [Abstract] [Full Text] [Related]

  • 12. Low-dose dual blockade of the renin-angiotensin system improves tubular status in non-diabetic proteinuric patients.
    Renke M, Tylicki L, Rutkowski P, Wojnarowski K, Lysiak-Szydlowska W, Rutkowski B.
    Scand J Urol Nephrol; 2005 Mar; 39(6):511-7. PubMed ID: 16303729
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target?
    Oruc N, Ozutemiz O, Nart D, Yuce G, Celik HA, Ilter T.
    Exp Toxicol Pathol; 2010 Jul; 62(4):353-60. PubMed ID: 19525099
    [Abstract] [Full Text] [Related]

  • 14. [Long-term captopril therapy in asymptomatic patients with severe chronic aortic insufficiency].
    Bisignani G, Serafini O, Caporale R, Guzzo D, Plastina F.
    G Ital Cardiol; 1997 Sep; 27(9):925-30. PubMed ID: 9378199
    [Abstract] [Full Text] [Related]

  • 15. Gene profiling of left ventricle eccentric hypertrophy in aortic regurgitation in rats: rationale for targeting the beta-adrenergic and renin-angiotensin systems.
    Champetier S, Bojmehrani A, Beaudoin J, Lachance D, Plante E, Roussel E, Couet J, Arsenault M.
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H669-77. PubMed ID: 19112094
    [Abstract] [Full Text] [Related]

  • 16. [Role of the cardiac renin-angiotensin system in hypertensive heart disease].
    Holmer SR, Riegger GA.
    Herz; 1995 Oct; 20(5):322-9. PubMed ID: 7498879
    [Abstract] [Full Text] [Related]

  • 17. Early left ventricular remodeling in acute severe aortic regurgitation: insights from an animal model.
    Lachance D, Plante E, Roussel E, Drolet MC, Couet J, Arsenault M.
    J Heart Valve Dis; 2008 May; 17(3):300-8. PubMed ID: 18592927
    [Abstract] [Full Text] [Related]

  • 18. New insights in the pathophysiology of mitral and aortic regurgitation in pediatric age: role of angiotensin-converting enzyme inhibitor therapy.
    Pisacane C, Pacileo G, Santoro G, Sarubbi B, Iacono C, Russo MG, Calabrò R.
    Ital Heart J; 2001 Feb; 2(2):100-6. PubMed ID: 11256536
    [Abstract] [Full Text] [Related]

  • 19. Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension.
    Devereux RB, Pickering TG, Cody RJ, Laragh JH.
    J Clin Hypertens; 1987 Mar; 3(1):87-103. PubMed ID: 3033158
    [Abstract] [Full Text] [Related]

  • 20. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ, Cangiano JL, Altieri PI, Escobales N.
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.